News

BMJ2d
Definition of remission and relapse in polymyalgia rheumatica: data from a literature search compared with a Delphi-based expert consensus
2 Department of Internal Medicine, General Hospital of Kufstein, Kufstein, Austria 3 Department of Internal Medicine I, Innsbruck Medical University, Innsbruck, Austria 4 Department of Internal ...
BMJ2d
Digital ulcers predict a worse disease course in patients with systemic sclerosis
2 Amsterdam Rheumatology Center/University of Amsterdam & Atrium Medical Center, Heerlen, The Netherlands 3 Leiden University Medical Center, Leiden, The Netherlands 15 Division of Rheumatology AOUC & ...
BMJ3d
Efficacy and safety of risankizumab for active psoriatic arthritis: 24-week results from the randomised, double-blind, phase 3 KEEPsAKE 2 trial
Objectives Risankizumab is an interleukin-23 inhibitor under study for the treatment of patients with psoriatic arthritis (PsA). The phase 3 KEEPsAKE 2 trial investigated the efficacy and safety of ...
BMJ3d
Lack of EULAR/ERA-EDTA response at 1 year predicts poor long-term renal outcome in patients with lupus nephritis
Objectives Short-term predictive endpoints of chronic kidney disease (CKD) are needed in lupus nephritis (LN). We tested response to therapy at 1 year. Results We studied 381 patients (90.5% ...
BMJ4d
Effect of baseline rheumatoid factor and anticitrullinated peptide antibody serotype on rituximab clinical response: a meta-analysis
Background Studies examining the relationship between serological status (rheumatoid factor and/or anticitrullinated antibody) and rituximab treatment outcome in rheumatoid arthritis (RA) have been ...
BMJ5d
Predictive factors of work disability in rheumatoid arthritis: a systematic literature review
1 Coronel Institute for Occupational and Environmental Health, Academic Medical Centre, Research Institute Amsterdam Centre for Health and Health Care Research (AmCOGG), Amsterdam, The Netherlands 2 ...
BMJ5d
Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: two-year efficacy and safety findings from AMPLE trial
Objectives To compare over 2 years the safety, efficacy and radiographic outcomes of subcutaneous abatacept versus adalimumab, in combination with methotrexate (MTX), in patients with rheumatoid ...
BMJ5d
Interpreting radiographic data in rheumatoid arthritis
Plain film radiography is the preferred method for evaluating disease progression in rheumatoid arthritis and for establishing the efficacy of new disease modifying antirheumatic agents. However, the ...
BMJ5d
Repair of bone erosions in rheumatoid arthritis treated with tumour necrosis factor inhibitors is based on bone apposition at the base of the erosion
1 Department of Internal Medicine 3, University of Erlangen–Nuremberg, Erlangen, Germany 2 Institute of Medical Physics, University of Erlangen–Nuremberg, Erlangen, Germany Correspondence to Georg ...
BMJ5d
Defining active sacroiliitis on MRI for classification of axial spondyloarthritis: update by the ASAS MRI working group
20 Amsterdam Rheumatology & Immunology Center, Academic Medical Center, Amsterdam, The Netherlands Correspondence to Dr Robert G W Lambert, Department of Radiology and Diagnostic Imaging, University ...
BMJ5d
Risk of mortality in patients with psoriatic arthritis, rheumatoid arthritis and psoriasis: a longitudinal cohort study
1 Division of Rheumatology, Center for Clinical Epidemiology and Biostatistics, Center for Pharmacoepidemiology Research and Training, Perelman School of Medicine at the University of Pennsylvania, ...
BMJ5d
Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients
Objectives: To identify the main causes of morbidity and mortality in patients with antiphospholipid syndrome (APS) during a 5-year period and to determine clinical and immunological parameters with ...